Global and China Drug Eluting Beads Market Insights, Forecast to 2026

Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.
The global drug eluting beads market is primarily driven by the increasing prevalence of liver diseases. Increasing awareness among people regarding the benefits of drug eluting beads therapy is also expected to drive the growth of the global drug eluting beads market. However, lack of skilled physicians is expected to restrain the market growth.

Market Analysis and Insights: Global and China Drug Eluting Beads Market
This report focuses on global and China Drug Eluting Beads QYR Global and China market.
The global Drug Eluting Beads market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Drug Eluting Beads Scope and Market Size
Drug Eluting Beads market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Drug Eluting Beads market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Drug Eluting Beads market is segmented into
Oncozene Beads
Quadra Sphere
LC Beads
Others

Segment by Application, the Drug Eluting Beads market is segmented into
Hospitals
Specialized Clinics
Research Centers
Ambulatory Surgical Centers

Regional and Country-level Analysis
The Drug Eluting Beads market is analysed and market size information is provided by regions (countries).
The key regions covered in the Drug Eluting Beads market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Drug Eluting Beads Market Share Analysis
Drug Eluting Beads market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Drug Eluting Beads business, the date to enter into the Drug Eluting Beads market, Drug Eluting Beads product introduction, recent developments, etc.
The major vendors covered:
Biocompatibles
BTG International
Merit Medical Systems
CeloNova BioSciences
ABK Biomedical
Boston Scientific
Medtronic
Merit Medical Systems
Surefire Medical
Terumo